APEX Biologix
PrivateLast Round
Debt
Apr 10, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
APEX Biologix is a medical device company that designs and manufactures regenerative medicine products, including autologous biologic systems for platelet-rich plasma, bone marrow concentrate, and protein concentrate.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
APEX Biologix Comparables
Compare APEX Biologix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Celling Biosciences | 93% | |
| EmCyte Corporation | 90% | |
| Royal Biologics | 89% |
APEX Biologix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Apr 10, 2026 | ||||
| Debt | Oct 14, 2025 | ||||
| Debt | Jul 15, 2025 | ||||
| Debt | Mar 24, 2025 | ||||
| Accelerator | Mar 28, 2022 | ||||
Buyout/LBO | Apr 16, 2021 |
APEX Biologix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RevTek Capital | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 51% MoM, from 3.3K to 5K.
- Oct 13, 2025
Grew 38% QoQ, from 50 to 69 employees.
APEX Biologix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access